Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen.
about
Current status of biomarkers for prostate cancerComparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupGene expression pathways of high grade localized prostate cancer.Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer.Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer.Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer.Characteristics of modern Gleason 9/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland.Contemporary management of men with high-risk localized prostate cancer in the United States.Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?Factors effective on survival after radical prostatectomy: To what extent is pre-operative biopsy Gleason scoring is confident in predicting the prognosis?Matched comparison of outcomes following open and minimally invasive radical prostatectomy for high-risk patients.Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis.
P2860
Q24600574-E64BEE2C-81E6-4346-BEC8-78351F59F643Q27011661-C0A80815-0F59-49CA-879D-5FF92E542705Q33832517-AE571A6C-C4B2-4172-A541-2835FAC1BE87Q34013761-7B884AC2-FB8E-4A09-8755-0A22052E10FDQ35605945-A2AE630D-79A2-43CA-B971-583E509DD1F9Q36236135-E1C68F9D-406E-41E4-A7BD-61BE1F13D32EQ37210051-845B6BD7-E2D3-4233-B748-EDFF79BF327EQ37689256-59AF249D-387B-4F4F-AF5F-BC29F7FD2EECQ38152998-0728635B-3856-423B-901D-71455D6DCB24Q38717765-327FF8CD-0E73-4A6B-8AF2-AB47FD17120EQ38946078-3ED45D2A-5253-4F62-8894-6705E4790AD8Q41851526-3B1CB5B4-90A0-40FD-BEC7-7F2B7CA39B8CQ42647426-EC659A02-EA8D-4CAF-A7E6-A93DD2A3E182Q43523307-437DEE83-B3AD-48EB-B3FF-2733AF8C3C6AQ43636349-6694FC6E-896B-4031-9CE8-5F1D5774DE0DQ48919141-BE07AB04-21CB-4A66-AF4B-4A2FAB834D81Q50948637-C5B11507-6ABF-424F-9ED2-B359543F2737Q55714340-4CADCCB4-2280-4CF3-BC1F-5B45440D4F80
P2860
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term survival after radic ...... on sum in pathologic specimen.
@ast
Long-term survival after radic ...... on sum in pathologic specimen.
@en
type
label
Long-term survival after radic ...... on sum in pathologic specimen.
@ast
Long-term survival after radic ...... on sum in pathologic specimen.
@en
prefLabel
Long-term survival after radic ...... on sum in pathologic specimen.
@ast
Long-term survival after radic ...... on sum in pathologic specimen.
@en
P2093
P2860
P1433
P1476
Long-term survival after radic ...... on sum in pathologic specimen.
@en
P2093
Jonathan I Epstein
Mark Schoenberg
Patrick C Walsh
Phillip M Pierorazio
Thomas J Guzzo
Trinity J Bivalacqua
P2860
P304
P356
10.1016/J.UROLOGY.2009.11.085
P407
P577
2010-03-29T00:00:00Z